INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 429
23/10/2015
Projectes
Termini exhaurit
COMISSIÓ EUROPEA
Horizon 2020 is the new EU funding programme for research and innovation running from 2014 to 2020. The Horizon 2020 societal challenge of ‘health, demographic change and wellbeing’ (SC1) for the years 2016 and 2017 is strategically orientated to 'promoting healthy ageing and personalised healthcare'.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 35,000 employees in 75 countries, and markets its products in more than 180 countries.
 
Premis
Termini exhaurit
FUNDACIÓN GRÜNENTHAL
Aquests treballs haurien de versar sobre el dolor, tant en l'àmbit epidemiològic, com experimental, farmacològic o clínic.
 
Recursos Humans
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
The objective of the EFSD/Lilly Research Fellowships is to encourage innovative research in the fields of diabetes and its complications, and to promote excellence in medical education. Applicants should have demonstrated their ability in the field of diabetes research.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 35,000 employees in 75 countries, and markets its products in more than 180 countries.
 
 
 
Informació últil
 
 No hi ha novetats
 
 
Banner-convocatories-tancament-02
Projectes
Termini exhaurit
COMISSIÓ EUROPEA
ERC Starting Grants are designed to support excellent Principal Investigators at the career stage at which they are starting their own independent research team or programme. This action is open to researchers of any nationality who intend to conduct their research activity in any Member State or Associated Country. Applicant Principal Investigators must demonstrate the ground breaking nature, ambition and feasibility of their scientific proposal.
 
Termini exhaurit
SOCIEDAD ESPAÑOLA DE NEUMOLOGÍA Y CIRUGÍA TORÁCICA
Donar suport a un projecte de recerca presentat per un soci de SEPAR sobre qualsevol aspecte rellevant (bàsic, clínic, epidemiològic, etc.), relacionat amb la salut pulmonar i les malalties respiratòries/toràciques.
 
Termini exhaurit
BILL & MELINDA GATES FOUNDATION
 
Termini exhaurit
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer's disease (AD), related dementias and cognitive aging. The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising drug discovery and development programs. In addition to funding academic programs, the ADDF also invests in and creates early stage biotechnology companies. The ADDF also co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation.
 
 
Borses de viatge
Termini exhaurit
SOCIEDAD ESPAÑOLA DE NEUMOLOGÍA Y CIRUGÍA TORÁCICA
Són ajuts per a facilitar l'estada en centres de reconegut prestigi nacional o estranger, amb l'objectiu de fomentar la formació continuada en recerca d'alta qualitat sobre salut i patologies respiratòries (amb independència de la titulació professional del solicitant).
 
Premis
Termini exhaurit
FUNDACIÓN COLEGIO DE MÉDICOS DE CÓRDOBA
 
Termini exhaurit
EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES
ESCMID has evolved to become Europe’s leading society in clinical microbiology and infectious diseases with members from all European countries and all continents. For more than 30 years, ESCMID has been an influential component in the professional lives of microbiologists and infectious disease specialists and now reaches more than 33’000 members and affiliated members around the world.
 
Recursos Humans
Termini exhaurit
THE SWISS GOVERNMENT
The Swiss Government, through the Federal Commission for Scholarships for Foreign Students (FCS), offers the Excellence Research Scholarships for foreign students.
The scholarships enable selected applicants to undertake a research in the realm of their PhD or their medical specialization in one of the 10 Swiss Public Universities, the two Swiss Federal Institutes of Technology, the public teaching and research institutes and the Universities of Applied Sciences.
 
Termini exhaurit
SOCIEDAD ESPAÑOLA DE NEUMOLOGÍA Y CIRUGÍA TORÁCICA
Subvencionar econòmicament a socis SEPAR que hagin finalitzat recentment la seva formació clínica com a residents en Pneumologia o Cirurgia Toràcica, Diplomats Universitaris en Infermeria o Diplomats Universitaris en Fisioteràpia, i desitgin formar-se en el camp de la recerca respiratòria, desenvolupant un projecte de recerca científic.
 
Termini exhaurit
AXA RESEARCH FUND
To fund basic research dedicated to a better understanding of risk. The word risk as we understand it is connected to: Phenomena that are perceived -or yet to be perceived-as hazards or threats and wich must be identified and mesured for frequency and impact.
 
Termini exhaurit
ALEXANDER VON HUMBOLDT FOUNDATION
 
Termini exhaurit
ALEXANDER VON HUMBOLDT FOUNDATION
 
 
 
 
Articles
 
Fatjó J*, Bowen J, García E, Calvo P, Rueda S, Amblás S, Lalanza JF. Epidemiology of Dog and Cat Abandonment in Spain (2008-2013). Animals 2015; 5(2): 426-441.
 
Oliveras A*, Sans-Atxer L, Vázquez S. ¿Es distinto el control de la presión arterial en mujeres que en hombres?. Hipertensión y Riesgo Vascular 2015; 32(4): 151-158.
 
Cabrera M*, García-Margallo MT, Goday A, Calvo-Bonacho E. Variación estacional del peso en población trabajadora. Hipertensión y Riesgo Vascular 2015; 32(4): 159-160.
 
García-Rodríguez A*, Alvarez-González MA, Seoane A. Intrauterine device removal from the sigmoid colon during a screening colonoscopy. Endoscopy 2015; 47(Suppl 1): E446.
 
Yang J, Huang T, Petralia F, Long Q, Zhang B, Argmann C, Zhao Y, Mobbs CV, Schadt EE, Zhu J, Tu Z*, GTEx Consortium (...,Guigó R,...). Synchronized age-related gene expression changes across multiple tissues in human and the link to complex diseases. Sci Rep 2015; 5: 15145.
 
Bruzzoni-Giovanelli H*, González JR*, Sigaux F, Villoutreix BO, Cayuela JM, Guilhot J, Preudhomme C, Guilhot F, Poyet JL, Rousselot P. Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia. Oncotarget 2015; 6(34): 36269-36277.
 
Santos JR*, Blanco JL, Masiá M, Gutiérrez F, Pérez-Elías MJ, Iribarren JA, Force L, Antela A, Knobel H, Salavert M, López Bernaldo De Quirós JC, Pino M, Paredes R, Clotet B, on behalf of the Integrase Resistance Study Group in Spain (INI-VAIN Study Group). Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences. J Antimicrob Chemother 2015; 70(11): 3087-3095.
 
Messager M, de Steur WO, van Sandick JW, Reynolds J, Pera MR, Mariette C, Hardwick RH, Bastiaannet E, Boelens PG, van de Velde CJ, Allum WH*, The EURECCA Upper GI Group. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre). Eur J Surg Oncol 2016; 42(1): 116-122.
 
Ibañez M*, Pozo O, Sancho JV, Orengo T, Haro G, Hernández F. Analytical strategy to investigate 3,4-methylenedioxypyrovalerone (MDPV) metabolites in consumers' urine by high-resolution mass spectrometry. Anal Bioanal Chem 2016; 408(1): 151-164.
 
Roquer J*, Giralt E, Cerdà G, Rodríguez-Campello A, Cuadrado E, Jiménez-Conde J, Vivanco R, Soriano C, Dégano IR, Ois A. Glycated Hemoglobin Value Combined with Initial Glucose Levels for Evaluating Mortality Risk in Patients with Ischemic Stroke. Cerebrovasc Dis 2015; 40(5-6): 244-250.
 
Tinoco D, Fullana MA*, Torrents-Rodas D, Bonillo A, Vervliet B, Blasco-Cubedo MJ, Farré M, Torrubia R. Conditioned Fear Acquisition and Generalization in Generalized Anxiety Disorder. Behav Ther 2015; 46(5): 627-639.
 
Arrospide A*, Rué M, van Ravesteyn NT, Comas M, Larrañaga N, Sarriugarte G, Mar J. Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation. BMC Cancer 2015; 15: 671.
 
Barrios C, Spector TD, Menni C*. Blood, urine and faecal metabolite profiles in the study of adult renal disease. Arch Biochem Biophys 2016; 589: 81-92.
 
Fondevilla E*, Grau S, Mojal S, Palomar M, Matas L, Gudiol F, on behalf of the VINCat Group. Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013. Expert Rev Anti Infect Ther 2016; 14(1): 137-144.
 
Llauradó G, Megia A, Cano A, Giménez-Palop O, Simon I, González-Sastre M, Berlanga E, Fernández-Veledo S, Vendrell J*, González-Clemente JM*. FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness. PLoS ONE 2015; 10(10): e0140222.
 
Bergé D, Mané A, Salgado P, Cortizo R, Garnier C, Gómez-Pérez L, DÍEZ-AJA C, Bulbena A, Pérez V. Predictors of Relapse and Functioning in First-Episode Psychosis: a Two-Year Follow-Up Study. Psychiat Serv 2016; 67(2): 227-233.
 
Escalante FA, del Baño F, Supervía A*. MDMA-induced angioedema treated with icatibant. Clin Toxicol 2015; 53(10): 1148-1149.
 
Marcos J*, Pozo O. Derivatization of steroids in biological samples for GC-MS and LC-MS analyses. Bioanalysis 2015; 7(19): 2515-2536.
 
Islam MA, Fagundo AB, Arcelus J, Agüera Z, Jiménez-Murcia S, Fernández JM, Tinahones FJ, de la Torre R, Botella C, Frühbeck G, Casanueva FF, Menchón JM, Fernández-Aranda F*. Olfaction in eating disorders and abnormal eating behavior: a systematic review. Front Psychol 2015; 6: 1431.
 
Rajmil L*, Siddiqi A, Taylor-Robinson D, Spencer N. Understanding the impact of the economic crisis on child health: the case of Spain. Int J Equity Health 2015; 14: 95.
 
Sampson JN*, Wheeler W, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir L, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, de Vivo I, McGlynn KA, Purdue MP, Rajaraman P, Adami HO, Ahlbom A, Albanes D, Amary MF, An SJ, Andersson U, Andriole Jr G, Andrulis IL, Angelucci E, Ansell SM, Arici C, Armstrong BK, Arslan AA, Austin MA, Baris D, Barkauskas DA, Bassig BA, Becker N, Benavente Y, Benhamou S, Berg CD, Van Den Berg D, Bernstein L, Bertrand KA, Birmann BM, Black A, Boeing H, Boffetta P, Boutron-Ruault MC, Bracci PM, Brinton LA, Brooks-Wilson AR, ____________, Burdett L, Buring JE, Butler MA, Cai Q, Cancel-Tassin G, Canzian F, Carrato A, Carreon T, Carta A, Chan JK, Chang ET, Chang GC, Chang IS, Chang J, Chang-Claude J, Chen CJ, Chen CY, Chen C, Chen CH, Chen C, Chen H, Chen K, Chen KY, Chen KC, Chen Y, Chen YH, Chen YS, Chen YM, Chien LH, Chirlaque MD, Choi JE, Choi YY, Chow WH, Chung CC, Clavel J, Clavel-Chapelon F, Cocco P, Colt JS, Comperat E, Conde L, Connors JM, Conti D, Cortessis VK, Cotterchio M, Cozen W, Crouch S, Crous M, Cussenot O, Davis FG, Ding T, Diver WR, Dorronsoro M, Dossus L, Duell EJ, Ennas MG, Erickson RL, Feychting M, Flanagan AM, Foretova L, Fraumeni Jr JF, Freedman ND, Beane Freeman LE, Fuchs CS, Gago-Domínguez M, Gallinger S, Gao YT, Gapstur SM, García-Closas M, García-Closas R, Gascoyne RD, Gastier-Foster J, Gaudet MM, Gaziano JM, Giffen C, Giles GG, Giovannucci EL, Glimelius B, Goggins M, Gokgoz N, Goldstein AM, Gorlick RG, Gross MD, Grubb III R, Gu J, Guan P, Gunter M, Guo H, Habermann TM, Haiman CA, Halai D, Hallmans G, Hassan M, Hattinger C, He Q, He X, Helzlsouer KJ, Henderson BE, Henriksson R, Hjalgrim H, Hoffman-Bolton J, Hohensee C, Holford TR, Holly EA, Hong YC, Hoover RN, Horn-Ross PL, Monawar Hosain GM, Hosgood III HD, Hsiao CF, Hu N, Hu W, Hu Z, Huang MS, Huerta JM, Hung JY, Hutchinson A, Inskip PD, Jackson RD, Jacobs EJ, Jenab M, Jeon HS, Ji BT, Jin G, Jin L, Johansen C, Johnson A, Jung YJ, Kaaks R, Kamineni A, Kane E, Kang CH, Karagas MR, Kelly RS, Khaw KT, Kim C, Kim HN, Kim JH, Kim JS, Kim YH, Kim YT, Kim YC, Kitahara CM, Klein AP, Klein RJ, Kogevinas M, Kohno T, Kolonel LN, Kooperberg C, Kricker A, Krogh V, Kunitoh H, Kurtz RC, Kweon SS, LaCroix A, Lawrence C, Lecanda F, Lee VH, Li D, Li H, Li J, Li YJ, Li Y, Liao L, Liebow M, Lightfood T, Wim WY, Lin CC, Lin D, Lindstrom S, Linet MS, Link BK, Liu C, Liu J, Liu L, Ljungberg B, Lloreta J, Di Lollo S, Lu D, Lund E, Malats N, Mannisto S, Le Marchand L, Marina N, Masala G, Mastrangelo G, Matsuo K, Maynadié M, McKay J, McKean-Cowdin R, Melbye M, Melin BS, Michaud DS, Mitsudomi T, Monnereau A, Montalvan R, Moore LE, Mortensen LM, Nieters A, North KE, Novak AJ, Oberg AL, Offit K, Oh IJ, Olson SH, Palli D, Pao W, Park IK, Park JY, Park KH, Patiño-García A, Pavanello S, Peeters PH, Perng RP, Peters U, Petersen G, Picci P, Pike MC, Porru S, Prescott J, Prokunina-Olson L, Qian B, Qiao YL, Rais M, Riboli E, Riby J, Risch HA, Rizatto C, Rodabough R, Roman E, Roupret M, Ruder AM, de Sanjosé S, Scelo G, Schned A, Schumacher FR, Schwartz K, Schwenn M, Scotlandi K, Seow A, Serra C, Serra M, Sesso HD, Setiawan VW, Severi G, Severson RK, Shanafelt TD, Shen H, Shen W, Shin MH, Shiraishi K, Shu XO, Siddiq A, Sierrasesúmaga L, Sihoe AD, Skibola CF, Smith A, Smith MT, Southey MC, Spinelli JJ, Staines A, Stampfer M, Stern MC, Stevens VL, Stolzenberg-Solomon RZ, Su J, Su WC, Sund M, Sung JS, Sung SW, Tan W, Tang W, Tardón A, Thomas D, Thompson CA, Tinker LF, Tirabosco R, Tjoneeland A, Travis RC, Trichopoulos D, Tsai FY, Tsai YH, Tucker M, Turner J, Vajdic CM, Vermeulen R, Villano DJ, Vineis P, Virtamo J, Visvanathan K, Wactawski-Wende J, Wang C, Wang CL, Wang JC, Wang J, Wei F, Weiderpass E, Weiner GJ, Weinstein SJ, Wentzensen N, White E, Witzig TE, Wolpin BM, Wong MP, Wu C, Wu G, Wu J, Wu T, Wu W, Wu X, Wu YL, Wunder JS, Xiang YB, Xu J, Xu P, Yang PC, Yang TY, Ye Y, Yin Z, Yokota J, Yoon HI, Yu CJ, Yu H, Yu K, Yuan JM, Zelenetz A, Zeleniuch-Jacquotte A, Zhang XC, Zhang Y, Zhao X, Zhao Z, Zheng H, Zheng T, Zheng W, Zhou B, Zhu M, Zucca M, Boca SM, Cerhan JR, Ferri GM, Hartge P, Hsiung CA, Magnani C, Miligi L, Morton LM, Smedby KE, Teras LR, Vijai J, Wang SS, Brennan P, Caporaso NE, Hunter DJ, Kraft P, Rothman N, Silverman DT, Slager SL, Chanock SJ, Chatterjee N*. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst 2015; 107(12): djv279.
 
Gama-Norton L, Ferrando E, Ruiz-Herguido C, Liu Z, Guiu J, Islam A, Lee S, Yan M, Guidos CJ, López-Bigas N, Maeda T, Espinosa L, Kopan R*, Bigas A*. Notch signal strength controls cell fate in the haemogenic endothelium. Nat Commun 2015; 6: 8510.
 
Ramírez R*, Pedro-Botet J, García M, Corbella E, Merino J, Zambón D, Corbella X, Pintó X, and the Xarxa de Unitats de Lípids i Arteriosclerosi (XULA) investigators group. Erectile Dysfunction and cardiovascular risk factors in a Mediterranean diet cohort. Intern Med J 2016; 46(1): 52-56.
 
Rozas E*, Martínez-Escala E, Gallardo F, Pujol RM. Progressive erythematous plaques in a young man. Int J Dermatol 2016; 55(1): e1-e3.
 
García-Algar O*, Cuadrado-González A, Falcon M. Utilidad del cribado toxicológico en pediatría. An Pediatr (Barc) 2016; 85(3): 160.e1-160.e4.
 
 
Tel: 93 316 04 00
Doctor Aiguader, 88
08003 Barcelona
Seguiu-nos a:
Twitter
Youtube
En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).